Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05617391 · ClinicalTrials.gov registry record
An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks
A clinical trial of Childhood Cancer and Cardiomyopathy, Primary, sponsored by St. Jude Children's Research Hospital.
- Active
- Registry status
- 1,303
- Enrollment target
- 1
- Study location
NCT05617391: Active study of Childhood Cancer and Cardiomyopathy, Primary, sponsored by St. Jude Children's Research Hospital.
NCT05617391 is a study of Childhood Cancer and Cardiomyopathy, Primary that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 1,303 participants, roughly in line with the 1,415-participant average among 23 other Childhood Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05617391, a study of Childhood Cancer and Cardiomyopathy, Primary, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 1,303 participants
- Enrollment target
- 1
- Study location
Study Summary
The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer. Primary Objective To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk. Secondary Objective To build a novel predictive model solely on smartwatch ECG to predict risk for cardiomyopathy.
Primary Outcome
To be obtained during SLIFE Human Performance Lab appointment. Participant will receive a resting (supine) 12-lead ECG using a GE Mac 2000 Resting ECG System (General Electric Healthcare, Milwaukee, WI, USA). This will be assessed with the Apple Smartwatch ECG recording to determine concordance of the two ECGs.
Conditions Studied
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,303 participants |
| Start Date | 2022-12-13 |
| Est. Completion | 2027-06 |
What the registry record for NCT05617391 still lists
NCT05617391 is an observational study that tracks outcomes without assigning an intervention. Its 1,303 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,415-participant average among 23 other Childhood Cancer trials with a reported enrollment target.
The record links to 2 conditions, with Childhood Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05617391 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05617391 about?
NCT05617391 is a clinical study titled "An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks". The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer. Primary Objective To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk. Secondary...
What is the current status of trial NCT05617391?
This trial is currently active not recruiting. The enrollment target is 1,303 participants. The study started on 2022-12-13. Estimated completion is 2027-06.
What conditions does trial NCT05617391 study?
This clinical trial studies the following conditions: Childhood Cancer, Cardiomyopathy, Primary.
Who is sponsoring clinical trial NCT05617391?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05617391 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05617391's enrollment target sits among peer trials
1,303 2nd of 23 the highest of 23 other Childhood Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preparing for Life and Academics for Young Childhood Cancer Survivors
RECRUITING · NA
-
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
RECRUITING · NA
-
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
RECRUITING · NA
-
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
RECRUITING · NA
-
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
RECRUITING · NA
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04171323 · 1,305 participants · NA
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
- NCT06517901 · 1,306 participants · NA
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI